Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California. more
Time Frame | GH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.25% | -2.06% | -0.55% |
1-Month Return | 11.74% | -1.92% | 2.72% |
3-Month Return | 29.03% | -10.4% | 7.66% |
6-Month Return | 8.08% | -4.6% | 10.15% |
1-Year Return | 18.88% | 4.06% | 27.53% |
3-Year Return | -67.53% | 1.94% | 32.31% |
5-Year Return | -59.28% | 36.48% | 89.2% |
10-Year Return | 0.5% | 97.46% | 194.59% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 214.38M | 286.73M | 373.65M | 449.54M | 563.95M | [{"date":"2019-12-31","value":38.01,"profit":true},{"date":"2020-12-31","value":50.84,"profit":true},{"date":"2021-12-31","value":66.26,"profit":true},{"date":"2022-12-31","value":79.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 70.72M | 92.53M | 122.91M | 156.32M | 227.05M | [{"date":"2019-12-31","value":31.15,"profit":true},{"date":"2020-12-31","value":40.75,"profit":true},{"date":"2021-12-31","value":54.13,"profit":true},{"date":"2022-12-31","value":68.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 143.66M | 194.19M | 250.74M | 293.21M | 336.90M | [{"date":"2019-12-31","value":42.64,"profit":true},{"date":"2020-12-31","value":57.64,"profit":true},{"date":"2021-12-31","value":74.43,"profit":true},{"date":"2022-12-31","value":87.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 67.01% | 67.73% | 67.11% | 65.23% | 59.74% | [{"date":"2019-12-31","value":98.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.08,"profit":true},{"date":"2022-12-31","value":96.31,"profit":true},{"date":"2023-12-31","value":88.2,"profit":true}] |
Operating Expenses | 226.03M | 449.14M | 661.74M | 837.59M | 901.62M | [{"date":"2019-12-31","value":25.07,"profit":true},{"date":"2020-12-31","value":49.82,"profit":true},{"date":"2021-12-31","value":73.39,"profit":true},{"date":"2022-12-31","value":92.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (82.37M) | (254.95M) | (411.00M) | (544.38M) | (564.73M) | [{"date":"2019-12-31","value":-8237100000,"profit":false},{"date":"2020-12-31","value":-25495000000,"profit":false},{"date":"2021-12-31","value":-41100100000,"profit":false},{"date":"2022-12-31","value":-54437800000,"profit":false},{"date":"2023-12-31","value":-56472500000,"profit":false}] |
Total Non-Operating Income/Expense | 25.21M | 14.45M | 27.88M | (105.58M) | 118.75M | [{"date":"2019-12-31","value":21.23,"profit":true},{"date":"2020-12-31","value":12.17,"profit":true},{"date":"2021-12-31","value":23.48,"profit":true},{"date":"2022-12-31","value":-88.91,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (69.72M) | (245.90M) | (384.47M) | (653.45M) | (478.76M) | [{"date":"2019-12-31","value":-6972300000,"profit":false},{"date":"2020-12-31","value":-24590400000,"profit":false},{"date":"2021-12-31","value":-38447000000,"profit":false},{"date":"2022-12-31","value":-65344900000,"profit":false},{"date":"2023-12-31","value":-47876400000,"profit":false}] |
Income Taxes | (1.87M) | 379.00K | 300.00K | 1.14M | 685.00K | [{"date":"2019-12-31","value":-164.35,"profit":false},{"date":"2020-12-31","value":33.27,"profit":true},{"date":"2021-12-31","value":26.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":60.14,"profit":true}] |
Income After Taxes | (67.85M) | (246.28M) | (384.77M) | (654.59M) | (479.45M) | [{"date":"2019-12-31","value":-6785100000,"profit":false},{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false}] |
Income From Continuous Operations | (67.85M) | (246.28M) | (384.77M) | (654.59M) | (479.45M) | [{"date":"2019-12-31","value":-6785100000,"profit":false},{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (67.85M) | (246.28M) | (384.77M) | (654.59M) | (479.45M) | [{"date":"2019-12-31","value":-6785100000,"profit":false},{"date":"2020-12-31","value":-24628300000,"profit":false},{"date":"2021-12-31","value":-38477000000,"profit":false},{"date":"2022-12-31","value":-65458800000,"profit":false},{"date":"2023-12-31","value":-47944900000,"profit":false}] |
EPS (Diluted) | (0.84) | (2.58) | (4.00) | (5.25) | (3.55) | [{"date":"2019-12-31","value":-84,"profit":false},{"date":"2020-12-31","value":-258,"profit":false},{"date":"2021-12-31","value":-400,"profit":false},{"date":"2022-12-31","value":-525,"profit":false},{"date":"2023-12-31","value":-355,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
GH | |
---|---|
Cash Ratio | 5.06 |
Current Ratio | 6.22 |
Quick Ratio | 5.85 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
GH | |
---|---|
ROA (LTM) | -16.08% |
ROE (LTM) | -609.28% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
GH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.04 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.04 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
GH | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 5.78 |
P/B | 55.67 |
Price/FCF | NM |
EV/R | 6.71 |
EV/Ebitda | NM |
Guardant Health Inc (GH) share price today is $32.36
Yes, Indians can buy shares of Guardant Health Inc (GH) on Vested. To buy Guardant Health Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Guardant Health Inc (GH) via the Vested app. You can start investing in Guardant Health Inc (GH) with a minimum investment of $1.
You can invest in shares of Guardant Health Inc (GH) via Vested in three simple steps:
The 52-week high price of Guardant Health Inc (GH) is $38.53. The 52-week low price of Guardant Health Inc (GH) is $15.81.
The price-to-earnings (P/E) ratio of Guardant Health Inc (GH) is
The price-to-book (P/B) ratio of Guardant Health Inc (GH) is 55.67
The dividend yield of Guardant Health Inc (GH) is 0.00%
The market capitalization of Guardant Health Inc (GH) is $4.30B
The stock symbol (or ticker) of Guardant Health Inc is GH